Jeffrey V. Poulton - EVP, Chief Financial Officer at Alnylam Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Financial Officer
Stock Symbol
ALNY on Nasdaq
All Insider Reports
All Insider Reports

Jeffrey V. Poulton - trading volume in the past year for Alnylam Pharmaceuticals, Inc.

Holdings reported by Jeffrey V. Poulton for Alnylam Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30.6K $7.73M $252.27 Nov 26, 2024 Direct
Restricted Stock Units 3.82K $603K $158.09 Feb 27, 2024 Direct Common Stock
Common Stock 57 $14.5K $254.48 Nov 25, 2024 by Managed Account
Stock Option (right to buy) 15.1K Mar 1, 2024 Direct Common Stock

Transactions reported by Jeffrey V. Poulton for Alnylam Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.